CytoMed Therapeutics Limited — Cash Flow (NASDAQ:GDTC) | MetaTrader

Open full chart

Financials

Overview Estratto Conto Statistics Dividends

Quarterly Annual

Cash from operating activities -1.04 M-2.6 M-1.98 M — Cash from investing activities -353.11 K-2.14 M824.58 K — Cash from financing activities 722.71 K8.28 M-47.5 K — Free cash flow -1.04 M-2.6 M-1.98 M —

Notizie

Il titolo di CytoMed balza dopo l’annuncio di partnership per trial clinico in Malesia

CytoMed stock jumps after announcing clinical trial partnership in Malaysia

CytoMed Therapeutics enters clinical trial agreement with Malaysian hospital

CytoMed Therapeutics secures $500,000 investment for subsidiary

CytoMed Therapeutics Limited (GDTC) Q2 2025 Earnings Call Prepared Remarks Transcript

CytoMed riporta risultati preclinici promettenti per il trattamento della leucemia

CytoMed reports promising preclinical results for leukemia treatment

CytoMed Therapeutics shareholders approve all proposals at annual meeting

CytoMed Therapeutics schedules annual shareholder meeting